-
Loading metrics
Economic evaluation of the second-line regimen of liposome irinotecan (II) combined with 5-FU/LV versus placebo combined with 5-FU/LV for locally advanced or metastatic pancreatic ductal adenocarcinoma in China
- Jinlong Huang,
- Hanyun Ye,
- Jingyang Lin,
- Dan Luo,
- Ping Huang,
- Xiaochun Zheng
x
- Published: June 22, 2026
- https://doi.org/10.1371/journal.pone.0351853